Pediatric Drug Development
At Bristol-Myers Squibb, we are committed to providing innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases.
To reach this end for the pediatric population, Bristol-Myers Squibb has developed a multi-disciplinary Pediatric Center of Excellence providing leadership and advice to therapeutic area teams, committees and management within Bristol-Myers Squibb to facilitate the development and availability of innovative and quality medicines according to the highest ethical and scientific standards to help extend and enhance the lives of infants, children and adolescents. Due to the small numbers of affected children in many diseases, we recognize that pediatric research can only be accomplished in collaboration with multiple sites across the globe and in partnership with pediatricians, academic institutions, health agencies and networks.
We work with these partners to facilitate the development and execution of novel scientific research and to fulfill pediatric regulatory requirements. Our goal is to collaborate with the best and most effective pediatric researchers and research organizations to achieve these goals. Additionally, we will optimize our existing clinical research programs by providing operational support and allowing researchers and institutions to focus on the science and patient care.
Here at Bristol-Myers Squibb, we have a long history of successful collaborations with Investigators, Cooperative Groups and Networks across the globe.
Thank you for your interest in working with us.
The BMS Pediatric Center of Excellence Leadership Team
Lisa Percival, MS, Global Regulatory
Pamela Zee, MD, Global Clinical Research
||To submit a question to the BMS Pediatric Center of Excellence, click here.
For further general information on Pediatric Research, please click here.